Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Photodynamic therapy for restenosis promising:

This article was originally published in Clinica

Executive Summary

Miravent Medical Technologies, based in Santa Barbara, California, has reported promising results in preclinical studies of its PhotoPoint treatment for preventing restenosis after balloon angioplasty. The treatment involves light-activation of an antiproliferative drug. The studies confirmed its ability to inhibit cellular proliferation in artery walls after vascular injury.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel